Intranasal Adipose-Derived MSC Extracellular Vesicles Confer Sustained Cognitive Improvement and Suppress Alzheimer’s Pathology in APP/PS1 Mice
Biomolecules · 2026
DOI: 10.3390/biom16060798 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Mengsi Tian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Translational Medicine of Ministry of Education & Key Laboratory of Brain Science Research and Transformation in Tropical …. Hauptthemen laut MEDLINE: Alzheimer Disease, Extracellular Vesicles, Mesenchymal Stem Cells, Adipose Tissue. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology of Hainan Province, National Natural Science Foundation of China, Hainan Province Science and Technology Special Fund.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) lacks effective disease-modifying therapies, and extracellular vesicles (EVs) derived from adipose-derived mesenchymal stromal cells (ADMSCs) have emerged as promising therapeutic candidates. In this study, we investigated the brain biodistribution and dose-dependent effects of intranasally administered ADMSC-EVs in female APP/PS1 mice, with age-matched wild-type mice and vehicle-treated transgenic mice serving as controls. EV biodistribution was assessed using PKH26 labeling, cognitive performance was evaluated using the Morris water maze, Y-maze, and novel object recognition tests, and hippocampal amyloid pathology and plasma AD-related biomarkers were analyzed. Intranasally delivered ADMSC-EVs rapidly reached multiple brain regions, including the hippocampus, improved learning and memory performance, and reduced hippocampal amyloid-β 1-42 (Aβ42) deposition and plaque burden. These effects followed a nonlinear dose–response pattern, with reduced efficacy at low doses and no additional benefits at high doses. Notably, partial behavioral and pathological benefits persisted after treatment cessation. Together, these findings show that intranasal ADMSC-EVs exert therapeutic effects in APP/PS1 mice and support the importance of dose optimization and post-treatment durability in the development of EV-based interventions for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Tropical Translational Medicine of Ministry of Education & Key Laboratory of Brain Science Research and Transformation in Tropical Environment of Hainan Province, School of Basic Medical Sciences, Hain…
ORCID-Profile: Qingyun Guo
Förderung
- Department of Science and Technology of Hainan Province
- National Natural Science Foundation of China
- Hainan Province Science and Technology Special Fund
- Hainan Provincial Natural Science Foundation of China
- Hainan Provincial Association for Science and Technology Program of Youth Science Talent and Academic Innovation
- Academic Enhancement Support Program of Hainan Medical University
Zitieren
APA
Tian, M., Feng, R., Gong, C., Ben, X., Ma, Z., Yi, X., & Guo, Q. (2026). Intranasal Adipose-Derived MSC Extracellular Vesicles Confer Sustained Cognitive Improvement and Suppress Alzheimer’s Pathology in APP/PS1 Mice. Biomolecules. https://doi.org/10.3390/biom16060798
Vancouver
Tian M, Feng R, Gong C, Ben X, Ma Z, Yi X, et al. Intranasal Adipose-Derived MSC Extracellular Vesicles Confer Sustained Cognitive Improvement and Suppress Alzheimer’s Pathology in APP/PS1 Mice. Biomolecules. 2026. doi:10.3390/biom16060798
BibTeX
@article{Tian2026,
author = {Tian, Mengsi and Feng, Renjun and Gong, Chunmei and Ben, Xinyu and Ma, Zhijian and Yi, Xinan and Guo, Qingyun},
title = {Intranasal Adipose-Derived MSC Extracellular Vesicles Confer Sustained Cognitive Improvement and Suppress Alzheimer’s Pathology in APP/PS1 Mice},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16060798}
}
EUVIMED